Alimera Sciences Inc (ALIM.OQ)

ALIM.OQ on NASDAQ Stock Exchange Global Market

5.82USD
3:45pm EDT
Price Change (% chg)

$-0.20 (-3.32%)
Prev Close
$6.02
Open
$6.02
Day's High
$6.02
Day's Low
$5.80
Volume
20,050
Avg. Vol
50,751
52-wk High
$8.43
52-wk Low
$1.65

ALIM.OQ

Chart for ALIM.OQ

About

Alimera Sciences, Inc.is a biopharmaceutical company that develops and commercializes prescription ophthalmic pharmaceuticals. The Company advanced product candidate, ILUVIEN, is a tiny, cylindrical polyimide tube that contains 190 g of fluocinolone acetonide (FAc), a corticosteroid with a history of treating ocular diseases.... (more)

Overall

Beta: 1.31
Market Cap (Mil.): $242.76
Shares Outstanding (Mil.): 40.33
Dividend: --
Yield (%): --

Financials

  ALIM.OQ Industry Sector
P/E (TTM): -- 35.48 35.85
EPS (TTM): -1.76 -- --
ROI: -153.46 18.97 18.25
ROE: -- 19.75 19.12
Search Stocks

Alimera makes fourth bid for eye treatment approval from FDA

- Alimera Sciences Inc said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindess in diabetes patients.

27 Mar 2014

Alimera makes fourth bid for eye treatment approval from FDA

March 27 - Alimera Sciences Inc said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindess in diabetes patients.

27 Mar 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks